Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

BSX - Boston Scientific Corporation... | Finranks

Home

/

BSX

B

Boston Scientific Corporation (BSX)

NYQ – Real Time Price. Currency in USD

50.67

-0.52 (-1.01%)

Market open: Aug 12, 2026, 10:14 AM EDT

51.25

+0.06 (0.12%)

Previous after-hours: Aug 11, 2026, 7:57 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

20.07B

16.75B

14.24B

12.68B

Cost of goods sold

-7.02B

-6.48B

-5.41B

-4.97B

Gross Profit

13.06B

10.27B

8.83B

7.71B

Operating expenses (excl. COGS)

-8.98B

-7.63B

-6.65B

-5.89B

Operating Income

4.07B

2.63B

2.18B

1.82B

Non-operating income, total

-687M

-353M

-196M

-683M

Pretax income

3.38B

2.28B

1.99B

1.14B

Equity in earnings

-

-

-

-

Taxes

-493M

-436M

-393M

-443M

Non-controlling/minority interest

6M

8M

1M

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

2.90B

1.85B

1.59B

698M

Discontinued operations

0

0

0

0

Net income

2.90B

1.85B

1.59B

698M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

23M

55M

Name

2025

2024

2023

2022

Total assets

43.67B+10.9%

39.40B+12.1%

35.14B+8.2%

32.47B

Total current assets

8.79B

6.92B

6.51B

5.76B

Total non-current assets

34.88B

32.48B

28.62B

26.71B

Total liabilities

19.20B+10.4%

17.39B+11.4%

15.61B+4.8%

14.90B

Total current liabilities

5.44B

6.40B

4.93B

3.80B

Total non-current liabilities

13.76B

10.99B

10.67B

11.09B

Total equity

24.47B

22B

19.53B

17.57B

Total liabilities & shareholders' equities

43.67B

39.40B

35.14B

32.47B

Total debt

11.97B+6.6%

11.23B+18.3%

9.49B+2.3%

9.28B

Name

2025

2024

2023

2022

Cash from operating activities

4.53B

3.44B

2.50B

1.53B

Cash from investing activities

-2.64B

-5.69B

-2.57B

-2.01B

Cash from financing activities

-395M

1.81B

5M

-548M

Free cash flow

3.66B+38.3%

2.65B+47.6%

1.79B+91.0%

938M